Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France[^1]. Founded in 1973, Sanofi has grown to become one of the world's leading healthcare companies, with a global presence spanning 90 countries and employing over 91,000 people[^2].


[[Dupilumab]] [[ALTUVIIIO]]

---
## Company Overview

Sanofi engages in the research, development, manufacturing, and marketing of a wide range of medicines and vaccines[^3]. The company's portfolio covers seven major therapeutic areas:

- Cardiovascular
- Central nervous system
- Diabetes
- Internal medicine
- Oncology
- Thrombosis
- Vaccines

As of 2023, Sanofi ranked 89th on the Forbes Global 2000 list[^4]. The company is also a component of the Euro Stoxx 50 stock market index[^4].

## History and Legacy

Sanofi's history is marked by several significant mergers and acquisitions:

- 1999: Merger of Sanofi and Synthélabo to form Sanofi-Synthélabo[^5].
- 2004: Merger with Aventis, creating Sanofi-Aventis[^5].
- 2011: Name changed back to Sanofi[^5].

The company's roots can be traced back to the 19th century, with a rich history of healthcare innovation[^6]. Sanofi has played a crucial role in advancing public health, particularly in the field of vaccines. It was the first worldwide supplier of the injectable polio vaccine and pioneered vaccines for influenza, meningitis, and rabies[^6].

## Key Achievements and Innovations

1. **Vaccines**: Sanofi's vaccine portfolio currently protects half a billion people worldwide[^7].

2. **Diabetes Care**: Since 1923, Sanofi has been at the forefront of diabetes innovation, supporting millions of patients globally[^7].

3. **Rare Diseases**: The company has made groundbreaking discoveries in enzyme replacement therapies for previously untreatable conditions like Gaucher, Fabry, and Pompe diseases[^7].

4. **Research and Development**: Sanofi maintains a robust pipeline, with 78 projects in clinical development as of 2024[^8].

## Global Impact

Sanofi's commitment to improving global health is evident in its extensive reach and innovative approaches:

- Present in over 90 countries[^7].
- Protects half a billion people worldwide with its vaccine portfolio[^7].
- Pioneering work in rare diseases and establishment of a Humanitarian Program for improved access to orphan drugs[^7]. 

## Financial Performance

In 2023, Sanofi reported:
- Revenue: €43.07 billion
- Operating Income: €7.875 billion
- Net Income: €5.4 billion[^9].

Sanofi continues to chase the miracles of science to improve people's lives, focusing on transforming the practice of medicine through breakthrough science and making a positive impact on the communities it serves[^8].

## Citations

[^1]: https://www.sanofi.com/en
[^2]: https://en.wikipedia.org/wiki/Sanofi
[^3]: https://www.globaldata.com/company-profile/sanofi/
[^4]: https://ko.wikipedia.org/wiki/%EC%82%AC%EB%85%B8%ED%94%BC
[^5]: https://www.sanofi.com/en/our-company/our-legacy
[^6]: https://www.sanofi.com/en/our-company
[^7]: https://www.sanofi.com/en/our-company/our-legacy
[^8]: https://www.sanofi.com/en/our-company
[^9]: https://www.sanofi.com/en/india/investors
